Compare Stocks → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:EDUTNASDAQ:EWEBNASDAQ:MAGXNASDAQ:XDNA Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEDUTGlobal X Education ETF$20.54$20.54$18.40▼$25.52$2.67M0.87477 shsN/AEWEBGlobal X Emerging Markets Internet & E-commerce ETF$21.14$21.14$18.42▼$25.54$2.54M0.42469 shsN/AMAGXRoundhill Daily 2X Long Magnificent Seven ETF$28.26-0.1%$26.39$22.58▼$28.36$2.83M3.398,990 shs738 shsXDNAKelly CRISPR & Gene Editing Technology ETF$7.38$7.38$5.87▼$11.83$2.21M0.923,034 shsN/AThe 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEDUTGlobal X Education ETF0.00%0.00%0.00%0.00%+5.39%EWEBGlobal X Emerging Markets Internet & E-commerce ETF0.00%0.00%0.00%0.00%-3.87%MAGXRoundhill Daily 2X Long Magnificent Seven ETF0.00%+3.82%+14.32%+2,825,999,900.00%+2,825,999,900.00%XDNAKelly CRISPR & Gene Editing Technology ETF0.00%0.00%0.00%0.00%-22.96%Bible Shocker: Have You Seen Elon Musk’s Miracle? (Ad)Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.Click here for the full story…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEDUTGlobal X Education ETFN/AN/AN/AN/AN/AN/AN/AN/AEWEBGlobal X Emerging Markets Internet & E-commerce ETFN/AN/AN/AN/AN/AN/AN/AN/AMAGXRoundhill Daily 2X Long Magnificent Seven ETFN/AN/AN/AN/AN/AN/AN/AN/AXDNAKelly CRISPR & Gene Editing Technology ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEDUTGlobal X Education ETF0.00N/A$26.9531.22% UpsideEWEBGlobal X Emerging Markets Internet & E-commerce ETF0.00N/A$23.9513.30% UpsideMAGXRoundhill Daily 2X Long Magnificent Seven ETFN/AN/AN/AN/AXDNAKelly CRISPR & Gene Editing Technology ETF0.00N/A$21.41190.05% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEDUTGlobal X Education ETFN/AN/AN/AN/AN/AN/AEWEBGlobal X Emerging Markets Internet & E-commerce ETFN/AN/AN/AN/AN/AN/AMAGXRoundhill Daily 2X Long Magnificent Seven ETFN/AN/AN/AN/AN/AN/AXDNAKelly CRISPR & Gene Editing Technology ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEDUTGlobal X Education ETFN/AN/A27.61∞N/AN/AN/AN/AN/AEWEBGlobal X Emerging Markets Internet & E-commerce ETFN/AN/A25.72∞N/AN/AN/AN/AN/AMAGXRoundhill Daily 2X Long Magnificent Seven ETFN/AN/A0.00∞N/AN/AN/AN/AN/AXDNAKelly CRISPR & Gene Editing Technology ETFN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEDUTGlobal X Education ETF$0.271.31%N/AN/AN/AEWEBGlobal X Emerging Markets Internet & E-commerce ETF$0.060.28%N/AN/AN/AMAGXRoundhill Daily 2X Long Magnificent Seven ETFN/AN/AN/AN/AN/AXDNAKelly CRISPR & Gene Editing Technology ETFN/AN/AN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipEDUTGlobal X Education ETFN/AEWEBGlobal X Emerging Markets Internet & E-commerce ETFN/AMAGXRoundhill Daily 2X Long Magnificent Seven ETFN/AXDNAKelly CRISPR & Gene Editing Technology ETFN/AInsider OwnershipCompanyInsider OwnershipEDUTGlobal X Education ETFN/AEWEBGlobal X Emerging Markets Internet & E-commerce ETFN/AMAGXRoundhill Daily 2X Long Magnificent Seven ETFN/AXDNAKelly CRISPR & Gene Editing Technology ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableEDUTGlobal X Education ETF147,000130,000N/ANot OptionableEWEBGlobal X Emerging Markets Internet & E-commerce ETFN/A120,000N/ANo DataMAGXRoundhill Daily 2X Long Magnificent Seven ETFN/A100,000N/AN/AXDNAKelly CRISPR & Gene Editing Technology ETFN/A300,000N/AOptionableEDUT, MAGX, XDNA, and EWEB HeadlinesRecent News About These CompaniesMay 15, 2024 | msn.comCRISPR can treat common form of inherited blindness, early data hintMarch 27, 2024 | biotechniques.comCRISPR gene editing: in summaryMarch 9, 2024 | markets.businessinsider.comCRISPR Technology Takes Center Stage at SXSW 2024 for the First TimeFebruary 15, 2024 | markets.businessinsider.comIntellia Collaborates With ReCode To Develop Gene Therapy For Cystic FibrosisJanuary 18, 2024 | techbullion.comCRISPR Technology: Unveiling the Breakthrough in Gene Editing and Its Far-Reaching ImplicationsJanuary 15, 2024 | msn.comHere's Why CRISPR Therapeutics Stock Rose 54% Last YearDecember 8, 2023 | news.yahoo.comGene editing is now a medical realityDecember 8, 2023 | news.yahoo.comFDA approves first use of CRISPR gene editing to treat sickle cell diseaseDecember 8, 2023 | markets.businessinsider.comFDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood DisorderNovember 24, 2023 | msn.comGene Editing Will Change Medicine—and Maybe Health Investing TooNovember 24, 2023 | phys.orgCRISPR/Cas9 unlocks TuMV resistance in Chinese cabbage: A leap forward in genome-edited plant breedingNovember 22, 2023 | msn.comIs CRISPR Therapeutics the Best Gene-Editing Stock?November 16, 2023 | technologyreview.comThree people were gene-edited in an effort to cure their HIV. The result is unknown.November 9, 2023 | markets.businessinsider.com3 Biotech Stocks That Are Betting on the Future of Gene EditingOctober 30, 2023 | msn.comCRISPR gene editing could kill HIV. But is it a cure?October 29, 2023 | labroots.comCRISPR Virtual Event Series 2023October 29, 2023 | phys.orgResearcher discusses CRISPR-Cas3 as a DNA shredder for gene therapyOctober 17, 2023 | msn.comCantor Fitzgerald Downgrades CRISPR Therapeutics (CRSP)October 3, 2023 | bates.eduCRISPR Gene Editing: Changing the Future of ScienceAugust 18, 2023 | technologynetworks.comCRISPR and Genome Editing – News and FeaturesNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsGlobal X Education ETFNASDAQ:EDUTThe Global X Education ETF (EDUT) is an exchange-traded fund that is based on the Indxx Global Education Thematic index, a market-cap-weighted index of global companies providing products and services that facilitate education. EDUT was launched on Jul 10, 2020 and is managed by Global X.Global X Emerging Markets Internet & E-commerce ETFNASDAQ:EWEBThe Global X Emerging Markets Internet & E-commerce ETF (EWEB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks an index of companies positioned to benefit from the advancement of internet and e-commerce technologies in emerging market countries. EWEB was launched on Nov 9, 2020 and is managed by Global X.Roundhill Daily 2X Long Magnificent Seven ETFNASDAQ:MAGXThe Roundhill Daily 2X Long Magnificent Seven ETF (MAGX) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund-of-funds aiming to achieve 2x the return, for a single day, of the Roundhill Magnificent Seven ETF (MAGS) through derivative instruments such as swaps. MAGX was launched on Feb 29, 2024 and is issued by Roundhill.Kelly CRISPR & Gene Editing Technology ETFNASDAQ:XDNAThe Strategic CRISPR & Gene Editing Technology ETF (XDNA) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market-cap-weighted index of companies in developed markets that focus on the advancements in DNA modification technology. XDNA was launched on Jan 12, 2022 and is managed by Kelly. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
